In the latest session, Axogen Inc. (NASDAQ: AXGN) closed at $8.99 down -15.11% from its previous closing price of $10.59. In other words, the price has decreased by -$1.60 from its previous closing price. On the day, 722696 shares were traded.
Ratios:
For a deeper understanding of Axogen Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.42 and its Current Ratio is at 3.28. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.68.
On May 09, 2022, Canaccord Genuity Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $10 to $15.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 11 when MARIANI PETER J sold 12,500 shares for $7.50 per share. The transaction valued at 93,809 led to the insider holds 63,603 shares of the business.
Wendell Amy McBride bought 10,000 shares of AXGN for $62,240 on Sep 06. The Director now owns 80,342 shares after completing the transaction at $6.22 per share. On Aug 23, another insider, Burke William P. Mr., who serves as the Director of the company, bought 10,000 shares for $6.56 each. As a result, the insider paid 65,600 and bolstered with 10,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 387.26M and an Enterprise Value of 422.07M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.54 while its Price-to-Book (P/B) ratio in mrq is 3.96. Its current Enterprise Value per Revenue stands at 2.77 whereas that against EBITDA is -24.23.
Stock Price History:
Over the past 52 weeks, AXGN has reached a high of $10.83, while it has fallen to a 52-week low of $3.45. The 50-Day Moving Average of the stock is 9.01, while the 200-Day Moving Average is calculated to be 7.35.
Shares Statistics:
For the past three months, AXGN has traded an average of 462.09K shares per day and 435.44k over the past ten days. A total of 42.45M shares are outstanding, with a floating share count of 40.54M. Insiders hold about 5.81% of the company’s shares, while institutions hold 75.80% stake in the company. Shares short for AXGN as of Feb 15, 2024 were 1.4M with a Short Ratio of 3.03, compared to 1.41M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.25% and a Short% of Float of 3.50%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.16, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.02, with high estimates of $0.04 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.12 and -$0.27 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is -$0.07, with 5 analysts recommending between $0.07 and -$0.2.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $41.65M this quarter.It ranges from a high estimate of $42.7M to a low estimate of $39.9M. As of the current estimate, Axogen Inc.’s year-ago sales were $36.16M, an estimated increase of 15.20% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $41.72M, an increase of 13.80% less than the figure of $15.20% in the same quarter last year. There is a high estimate of $43M for the next quarter, whereas the lowest estimate is $40.5M.
A total of 6 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $158.8M, while the lowest revenue estimate was $156M, resulting in an average revenue estimate of $157.71M. In the same quarter a year ago, actual revenue was $138.58M, up 13.80% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $178.85M in the next fiscal year. The high estimate is $181.7M and the low estimate is $177M. The average revenue growth estimate for next year is up 13.40% from the average revenue estimate for this year.
